GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guerbet SA (XPAR:GBT) » Definitions » Institutional Ownership

Guerbet (XPAR:GBT) Institutional Ownership : 14.53% (As of May. 14, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Guerbet Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Guerbet's institutional ownership is 14.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Guerbet's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Guerbet's Float Percentage Of Total Shares Outstanding is 0.00%.


Guerbet Institutional Ownership Historical Data

The historical data trend for Guerbet's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guerbet Institutional Ownership Chart

Guerbet Historical Data

The historical data trend for Guerbet can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 16.34 16.60 16.75 16.36 16.33 16.50 16.06 14.47 14.50 14.53

Guerbet Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Guerbet (XPAR:GBT) Business Description

Traded in Other Exchanges
Address
15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.